Extended Data Fig. 4: Staining of yeast clones with cognate p/HLA-A*02:01.
From: Facile repurposing of peptide–MHC-restricted antibodies for cancer immunotherapy
a NY-ESO1 yeast clones (WT, N1, N4 & N5) were stained with serial diluted NY-ESO1/HLA-A*02:01. The numbers of AlexaFluor 647 positive cells with different NY-ESO1/HLA-A*02:01 concentration are shown as mean±s.d. (n = 3 biological replicates). b MART1 yeast clones (MA2 & MA5) were stained with serial diluted MART1/HLA-A*02:01. The numbers of AlexaFluor 647 positive cells with different MART1/HLA-A*02:01 concentration are shown as mean±s.d. (n = 3 biological replicates). c GP100 yeast clones (gp1 & gp11) were stained with serial diluted GP100/HLA-A*02:01. The numbers of AlexaFluor 647 positive cells with different GP100/HLA-A*02:01concentration are shown as mean±s.d. (n = 3 biological replicates). d KRAS yeast clones (RAS1 & RAS2) were stained with serial diluted KRAS/HLA-A*02:01. The numbers of AlexaFluor 647 positive cells with different KRAS/HLA-A*02:01 concentration are shown as mean±s.d. (n = 3 biological replicates).
